The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Digital Insomnia Therapeutics Market Research Report 2025

Global Digital Insomnia Therapeutics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1743653

No of Pages : 87

Synopsis
Global Digital Insomnia Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Digital Insomnia Therapeutics market research.

Key companies engaged in the Digital Insomnia Therapeutics industry include Headspace Inc, Big Health, Calm, Nox Health, Pear Therapeutics, OPTT Inc, SilverCloud, Curv Health and Bodymatter Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Digital Insomnia Therapeutics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Digital Insomnia Therapeutics market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Digital Insomnia Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Headspace Inc
  • Big Health
  • Calm
  • Nox Health
  • Pear Therapeutics
  • OPTT Inc
  • SilverCloud
  • Curv Health
  • Bodymatter Inc
  • PrimeNap

Segment by Type

  • Sleep Tracking App
  • Relaxation and Meditation Apps
  • CBT-I
  • Others

Segment by Application

  • Medical
  • Household

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Digital Insomnia Therapeutics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Insomnia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sleep Tracking App
1.2.3 Relaxation and Meditation Apps
1.2.4 CBT-I
1.2.5 Others
1.3 Market by Application
1.3.1 Global Digital Insomnia Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Household
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Insomnia Therapeutics Market Perspective (2018-2029)
2.2 Digital Insomnia Therapeutics Growth Trends by Region
2.2.1 Global Digital Insomnia Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Digital Insomnia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Digital Insomnia Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Digital Insomnia Therapeutics Market Dynamics
2.3.1 Digital Insomnia Therapeutics Industry Trends
2.3.2 Digital Insomnia Therapeutics Market Drivers
2.3.3 Digital Insomnia Therapeutics Market Challenges
2.3.4 Digital Insomnia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Insomnia Therapeutics Players by Revenue
3.1.1 Global Top Digital Insomnia Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Digital Insomnia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Digital Insomnia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Digital Insomnia Therapeutics Revenue
3.4 Global Digital Insomnia Therapeutics Market Concentration Ratio
3.4.1 Global Digital Insomnia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Insomnia Therapeutics Revenue in 2022
3.5 Digital Insomnia Therapeutics Key Players Head office and Area Served
3.6 Key Players Digital Insomnia Therapeutics Product Solution and Service
3.7 Date of Enter into Digital Insomnia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Insomnia Therapeutics Breakdown Data by Type
4.1 Global Digital Insomnia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Digital Insomnia Therapeutics Forecasted Market Size by Type (2024-2029)
5 Digital Insomnia Therapeutics Breakdown Data by Application
5.1 Global Digital Insomnia Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Digital Insomnia Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Digital Insomnia Therapeutics Market Size (2018-2029)
6.2 North America Digital Insomnia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Digital Insomnia Therapeutics Market Size by Country (2018-2023)
6.4 North America Digital Insomnia Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Insomnia Therapeutics Market Size (2018-2029)
7.2 Europe Digital Insomnia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Digital Insomnia Therapeutics Market Size by Country (2018-2023)
7.4 Europe Digital Insomnia Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Insomnia Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Digital Insomnia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Digital Insomnia Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Digital Insomnia Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Insomnia Therapeutics Market Size (2018-2029)
9.2 Latin America Digital Insomnia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Digital Insomnia Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Digital Insomnia Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Insomnia Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Digital Insomnia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Digital Insomnia Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Headspace Inc
11.1.1 Headspace Inc Company Detail
11.1.2 Headspace Inc Business Overview
11.1.3 Headspace Inc Digital Insomnia Therapeutics Introduction
11.1.4 Headspace Inc Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.1.5 Headspace Inc Recent Development
11.2 Big Health
11.2.1 Big Health Company Detail
11.2.2 Big Health Business Overview
11.2.3 Big Health Digital Insomnia Therapeutics Introduction
11.2.4 Big Health Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.2.5 Big Health Recent Development
11.3 Calm
11.3.1 Calm Company Detail
11.3.2 Calm Business Overview
11.3.3 Calm Digital Insomnia Therapeutics Introduction
11.3.4 Calm Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.3.5 Calm Recent Development
11.4 Nox Health
11.4.1 Nox Health Company Detail
11.4.2 Nox Health Business Overview
11.4.3 Nox Health Digital Insomnia Therapeutics Introduction
11.4.4 Nox Health Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.4.5 Nox Health Recent Development
11.5 Pear Therapeutics
11.5.1 Pear Therapeutics Company Detail
11.5.2 Pear Therapeutics Business Overview
11.5.3 Pear Therapeutics Digital Insomnia Therapeutics Introduction
11.5.4 Pear Therapeutics Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.5.5 Pear Therapeutics Recent Development
11.6 OPTT Inc
11.6.1 OPTT Inc Company Detail
11.6.2 OPTT Inc Business Overview
11.6.3 OPTT Inc Digital Insomnia Therapeutics Introduction
11.6.4 OPTT Inc Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.6.5 OPTT Inc Recent Development
11.7 SilverCloud
11.7.1 SilverCloud Company Detail
11.7.2 SilverCloud Business Overview
11.7.3 SilverCloud Digital Insomnia Therapeutics Introduction
11.7.4 SilverCloud Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.7.5 SilverCloud Recent Development
11.8 Curv Health
11.8.1 Curv Health Company Detail
11.8.2 Curv Health Business Overview
11.8.3 Curv Health Digital Insomnia Therapeutics Introduction
11.8.4 Curv Health Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.8.5 Curv Health Recent Development
11.9 Bodymatter Inc
11.9.1 Bodymatter Inc Company Detail
11.9.2 Bodymatter Inc Business Overview
11.9.3 Bodymatter Inc Digital Insomnia Therapeutics Introduction
11.9.4 Bodymatter Inc Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.9.5 Bodymatter Inc Recent Development
11.10 PrimeNap
11.10.1 PrimeNap Company Detail
11.10.2 PrimeNap Business Overview
11.10.3 PrimeNap Digital Insomnia Therapeutics Introduction
11.10.4 PrimeNap Revenue in Digital Insomnia Therapeutics Business (2018-2023)
11.10.5 PrimeNap Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’